XEN1101
XPF-008-201
Phase 3 small_molecule active
Quick answer
XEN1101 for Focal Epilepsy is a Phase 3 program (small_molecule) at Xenon Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Xenon Pharmaceuticals
- Indication
- Focal Epilepsy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active